Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted MyelomaMarco Ladetto, Antonio Palumbo, Luca De Rosa et al.|Journal of Clinical Oncology|2010Cited by 268
Correlation Between Clinical Outcome and Disease Kinetics by Quantitative PCR in Myeloma Patients Following Post-Transplant Consolidation with Bortezomib, Thalidomide and Dexamethasone.Marco Ladetto, Antonio Palumbo, Mariella Grasso et al.|Blood|2009Cited by 6